|
第七章 參考資料 Abe J and Berk BC: Hypoxia and HIF-1alpha stability: another stress-sensing mechanism for Shc. Cir. Res. 91: 4-6, 2002 . Acker T and Plate KH : Role of hypoxia in tumor angiogenesis-molecular and cellular angiogenic crosstalk. Cell & Tissue Res. 314: 145-55, 2003. Agostinelli E and Seiler N: Non-irradiation-derived reactive oxygen species (ROS) and cancer: therapeutic implications. Amino Acids 31: 341–355, 2006. Ang KK, Berkey BA, Tu X, Zhang HZ, Katz R, Hammond EH, Fu KK and Milas L: Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Res. 15: 7350-7356, 2002. Arbiser JL, Petros J, Klafter R, Govindajaran B, McLaughlin ER and Brown LF: Reactive oxygen generated by Nox1 triggers the angiogenic switch. Proc. Natl. Acad. Sci. USA 99: 715–720, 2002. Archer SL, Reeve HL, Michelakis E, Puttagunta L, Waite R, Nelson DP, Dinauer MC and Weir EK: O-2 sensing is preserved in mice lacking the gp91 phox subunit of NADPH oxidase. Proceed. Natl. Acad. Sci. 96: 7944–7949, 1999. Aust SD, Chignell CF, Bray TM, Kalyanaraman B and Mason RP: Contemporary issues in toxicology: free radicals in toxicology. Toxicol. Appl. Pharmacol. 120: 168-178, 1993. Bannister JV, Bannister WH and Rotilio G: Aspects of the structure, function, and applications of superoxide dismutase. CRC Crit. Rev. Biochem. 22: 111-80, 1987. Baselga J: The EGFR as a target for anticancer therapy--focus on cetuximab. Eur. J. Cancer 37: S16-22, 2001. Bast A, Haene GRMM and Doelman CJA: Oxidants and antioxidants: state of the art. Am. J. Med. 91: 2-13, 1991. Beasley NJP,Leek R, Alam M, Turley H, Cox GJ, Gatter K, Millard P, Fuggle S, and Harris AL: Hypoxia-inducible factors HIF-1α and HIF-2α in head and neck cancer: relationship to tumor biology and treatment outcome in surgically resected patients. Cancer Res. 62: 2493–2497, 2002. Belozerov VE and Van Meir EG: Hypoxia inducible factor-1: a novel target for cancer therapy. Anti-cancer Drugs 16: 901-909, 2005 Benohr HC and Waller HD: Gluathione. Klin. Wochenschr. 53: 789-820, 1975. Blouin, C. C., Page, E. L., Soucy, G. M., and Richard, D. E : Blood.103, 1124–1130, 2004. Bos R, van Diest P J, de Jong J S, van der Groep P, van der Valk P, van der Wall E: Hypoxia-inducible factor-1α is associated with angiogenesis, and expression of bFGF, PDGF-BB, and EGFR in invasive breast cancer. Histopathology 46: 31-36, 2005. Bowler RP, and Crapo JD: Oxidative stress in allergic respiratory disease. J. Allergy Clin. Immunol. 110: 349-356, 2002. Brar SS, Kennedy TP, Quinn M and Hoidal JR: Redox signaling of NF-kappaB by membrane NAD(P)H oxidases in normal and malignant cells. Protoplasma 221: 117–127, 2003. Brown JM and Giaccia GW. The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res. 58: 1408-1416, 1998. Brown JM: The hypoxia cell: a target for selective cancer therapy. Cancer Res. 59: 5863-70, 1999. Bunn HF and Poyton RO: Oxygen sensing and molecular adaptation to hypoxia. Physiol. Rev. 76: 839–885, 1996. Caslino-Matsuda SM, Monzon ME and Forteza RM: Epidermal Growth Factor Receptor Activation by Epidermal Growth Factor Mediates Oxidant-Induced Goblet Cell Metaplasia in Human Airway Epithelium. J. Resp Cell .Mol. Bio. 34: 581-599, 2006. Chang CK, Tsai CY, Lin LS, Jou SB, Liao SS and Cheng JT: Changes of superoxide dismutase(SOD)mRNA and activity in response to hypoxic stress in cultured Wistar rat glioma cells. Neurosci Lett 232:115-118, 1997. Chang TC, Huang CJ, Tam K, Chen SF, Tan KT, Tsai MS, Lin TN, and Shyue SK: Stabilization of Hypoxia-inducible Factor-1 by Prostacyclin under Prolonged Hypoxia via Reducing Reactive Oxygen Species Level in Endothelial Cells, J. Biol. Chem. 280: 36567-36574,2005. Chang YS. di Tomaso E. McDonald DM. Jones R. Jain RK and Munn LL: Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood. Sci. 97: 14608-14613, 2000. Chen X, Liang H, Van Remmen H, Vijg J, and Richardson A: Catalase transgenic mice: characterization and sensitivity to oxidative stress. Arch. Biochem. Biophys. 422: 197-210, 2004. Church SL. Grant JW. Ridnour LA. Oberley LW. Swanson PE. Meltzer PS and Trent JM: Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells.Proc.Natl. Acad.Sci. USA. 90:3113-7, 1993. Ciardiello F, Caputo R, Bianco R, Damiano V, Fontanini G, Cuccato S, De Placido S, Bianco AR, and Tortora G: Inhibition of Growth Factor Production and Angiogenesis in Human Cancer Cells by ZD1839 (Iressa), a Selective Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor. Clin. Cancer Res. 7: 1459-1465, 2001. Coquette A,Vray B and Vanderpas J: Role of vitamin E in the protection of the resident macrophage membrance against oxidative damage. Arch. Int. Physiol. Biochem. 94: S29-34, 1986. Cotgreave IA, Moldeus P and Orrenius S: Host biochemical defense mechanisms against prooxidants. Annu. Rev. Pharmacol.Toxicol. 28: 189-212, 1988. Cotgreave IA, Moldeus P and Orrenius S: Host biochemistry and pathology of radical-mediated protein oxidation. Biochem. J. 324:1-8, 1997. Douziech N, Calvo E, Laine J. and Morisset J: Activation of MAP kinases in growth responsive pancreatic cancer cells. Cell Signal. 11: 591–602, 1999. Ebert BL, Gleadle JM, O'Rourke JF, Bartlett SM, Poulton J. and Ratcliffe PJ: Isoenzyme-specific regulation of genes involved in energy metabolism by hypoxia: Similarities with the regulation of erythropoietin. Biochem. J. 313: 809–814, 1996. Eriksson U and Alitalo K: Structure, expression and receptor-binding properties of novel vascular endothelial growth factors. Curr. Top Microbiol. Immunol. 237: 41-57, 1999. Ferrara N and Davis-Smyth T: The biology of vascular endothelial growth factor. Endocrine Rev. 18: 4-25, 1997. Folkman J: Fighting cancer by attacking its blood supply. Sci. Am. 275: 150-154, 1996. Folkman J: Role of angiogenesis in tumor growth and metastasis. Semin. Oncol. 29: 15–18, 2002. Franco-Obregon A, Ureña J and Lopez-Barneo J: Oxygen-sensitive calciium channels in vascular smooth muscle and their possible role in hypoxic arterial relaxation. Proc.Natl.Acad.Sci.USA. 92: 4715– 4719, 1995. Gale NW and Yancopoulos GD: Growth factor acting via endothelial cell-specific receptor tyrosine kinases:VEGFs, angiopoietins, and ephrins in vascular development. Gene & Develop. 13: 1055-1066, 1999. Gerald D, Berra E, Frapart YM, Chan DA, Giaccia AJ, Mansuy D, Pouyssegur J, Yaniv M and Mechta-Grigoriou F: JunD reduces tumor angiogenesis by protecting cells from oxidative stress. Cell 118:781-94, 2004. Görlach, A, Diebold I and Schini-Kerth VB, Berchner-Pfannschmidt U, Roth U, Brandes RP, Kietzmann T and Busse R: Thrombin Activates the Hypoxia-Inducible Factor-1 Signaling Pathway in Vascular Smooth Muscle Cells: Role of the p22phox-Containing NADPH Oxidase. Circ. Res. 89:47-54, 2001. Goyal P, Weissmann N, Grimminger F, Hegel C, Bader L, Rose F,Fink L, Ghofrani HA, Schermuly RT, Schmidt HHHW, Seeger W and Hänze J:Upregulation of NAD(P)H oxidase 1 in hypoxia activates hypoxia-inducible factor 1 via increase in reactive oxygen species. Free Radical Bio. Med. 36: 1279-1288, 2004. Hancock JT, Desikan R and Neill S: Role of reactive oxygen species in cell signaling pathways. J Biochem Soc Trans 29; 345-350, 2001. Herbst RS and Shin DM: Monoclonal antibodies to target epidermal growth factor receptor-positive tumors: a new paradigm for cancer therapy. Cancer 94: 1593-1611, 2002. Hirata A, Ogawa S-I, Kometani T, Kuwano T, Naito S, Kuwano M, Ono M: ZD1839 (Iressa) Induces Antiangiogenic Effects through Inhibition of Epidermal Growth Factor Receptor Tyrosine Kinase. Cancer Res. 62: 2554-2560, 2002. Hoidal JR: Reactiver ocygen sp0ecies and cell signaling. Am. J. Respir. Cell Mol. Biol. 25; 661-663, 2001. Houck KA, Leung DW, Rowland AM, Winer J and Ferrara N: Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms, J. Bio. Chem. 267: 26031-26037, 1992. Huang LE. Gu J. Schau M and Bunn HF: Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc. Natl. Acad. Sci. USA 95: 7987-92, 1998. Huang SM, Bock JM and Harari PM: Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck. Cancer Res. 59: 1935-1940, 1999. Huang Y, He T and Domann F.E: Decreased MnSOD expression in transformed cells is associated with increased cytosine methylation of the SOD2 gene. DNA Cell Biol. 18: 643-652, 1999. Ivan M, Kondo K, Yang H, Kim W, Valiando J, Ohh M, Salic A, Asara J M, Lane WS and Kaelin WG: HIF alpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 292: 464–468, 2001. Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, Kriegsheim AV, Hebestreit HF, Mukherji M and Schofield CJ: Targeting of HIF-alpha to the von Hippel–Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292: 468–472, 2001. Jefferson JA, Simoni J, Escudero E, Hurtado ME, Swenson ER, Wesson DE, Schreiner GF, Schoene RB, Johnson RJ and Hurtado A: Increased oxidative stress following acute and chronic high altitude exposure. High Altit. Med. Biol. 5: 61-9, 2004. Kallio PJ. Wilson WJ, O'Brien S, Makino Y and Poellinger L: Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway. J. Bio. Chem. 274: 6519-25, 1999. Kazzaz JA, Xu J, Palaia TA, Mantell L, Fein AM, and Horowitz S: Cellular oxygen toxicity. J. Biol. Chem. 271: 15182-6, 1996. Ke LD, Adler-Storthz K, Clayman GL, Yung AW and Chen Z: Differential expression of epidermal growth factor receptor in human head and neck cancers. Head Neck 20: 320–327, 1998. Kietzmann T and Görlach A: Reactive oxygen species in the control of hypoxia-inducible factor-mediated gene expression. Semin Cell Dev. Biol. 16: 474-86, 2005. Kinnula VL and Crapo JD: Superoxide DIsmutasea in the Lung and Human Lung Disease, Am.J. Respir crit Care Med. 167:1600-1619, 2003. Klagsbrun V and D’Amore PA: Vascular endothelial growth fctor and its receptors. Cytokine & Growth Factor Rev. 7: 259-270, 1996. Kong S and Davison AJ: The role of interactions between O2, H2O2, .OH,e- and O2- in free radical damage to biological systems. Arch. Biochem. Biophys. 204:18-29, 1980. Koukourakis MI,Giatromanolaki A,Sivridis E,Simopoulos C,Turley H,Talks K,Gatter KC and Harris AL:Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 53: 1192–1202, 2002. Kuppuswamy D. and Pike LJ: Desensitization of the EGF receptor alters its ability to undergo EGF-induced dimerization, Cell Signal 3: 107–117, 1991. Kuroki M, Voest EE, Amano S, Beerepoot LV, Takashima S and Tolentino M: Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo, J. Clin. Invest. 98: 1667-1675, 1996. Kyzas PA, Stefanou D, Batistatou A and Agnantis NJ: Hypoxia-induced tumor angiogenic pathway in head and neck cancer: an in vivo study. Cancer Let. 225: 297-304, 2005. Kyzas PA, Stefanou D, Batistatou A, Agnantis NJ: Hypoxia-induced tumor angiogenic pathway in head and neck cancer: an in vivo study. Cancer Letter 225: 297-304, 2005. Lahiri S: Historical perspectives of cellular oxygen sensing and responses to hypoxia. J. Appl. Physiol. 88: 1467–1473, 2000. Lando D, Peet DJ, Whelan DA, Gorman JJ and Whitelaw ML: Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science 295: 858-861, 2002. Li JJ, Oberley LW, St Clair DK, Ridnour LA, and Oberley TD: Phenotypic changes induced in human breast cancer cell by overexpression of manganese-containing superoxide dismutase. Oncogene. 10: 1989-2000, 1995. Liang BC, Ross DA, Greenburg HS, Meltzer PS and TrentJ M: Evidence for allelic imbalance of chromosome 6 in human astrocytomas, Neurology. 44: 533-536, 1994. Liang K, Ang KK, Milas L, Hunter N and Fan Z : The epidermal growth factor receptor mediates radioresistance. Int. J. Radiat. Oncol. Biol. Phys. 57: 246-54, 2003. Liu LZ, Hu XW, Xia C, He J, Zhou Q, Shi X, Fang J and Jiang BH: Reactive oxygen species regulate epidermal growth factor-induced vascular endothelial growth factor and hypoxia-inducible factor-1alpha expression through activation of AKT and P70S6K1 in human ovarian cancer cells. Free Radic. Biol. Med. 41: 1521-33, 2006. Lu DY, Liou HC, Tang CH and Fu WM: Hypoxia-induced iNOS expression in microglia is regulated by the PI3-kinase/Akt/mTOR signaling pathway and activation of hypoxia inducible factor-1α. Biochem.Pharmacol.72:992-1000, 2006 Machlin LJ and Bendich A: Free radical tissue damage: protective role of antioxidant nutrients. FASEB J. 1: 441-445, 1987. Magalhaes J, Ascensao A, Soares JM, Neuparth MJ, Ferreira R, Oliveira J, Amado F and Duarte JA: Acute and severe hypobaric hypoxia-induced muscle oxidative stress in mice: the role of glutathione against oxidative damage. Eur. J. Appl. Physiol. 91: 185-191, 2004. Manea A,Constantinescu E, Popor D and Raicu M:Chang in oxidative balance in rat pericytes exposed to diabetic conditions. J.cell.Mol.Med. 8: 117-126, 2004. Marx J: How cells endure low oxygen. Science 303: 1454–1456, 2004. Marshall C, Mamary AJ, Verhoven AJ and Marshall BE: Pulmonary artery NADPH-oxidase is activated in hypoxic pulmonary vasoconstriction. Am. J Resp Cell. Mol.Bio.15: 633-644, 1996. Mateo J,Garcia-Lecea M, Cadenas S, Hernandez C and Moncada S: Regul -ation of hypoxia-inducible factor-1alpha by nitric oxide through mitochondria dependentand-independent pathways.Biochem.J.376: 537-544, 2003 Maxwell PH, Pugh CW, Ratcliffe PJ: Inducible operation of the erythropoietin 3" enhancer in multiple cell lines: Evidence for a widespread oxygen-sensing mechanism. Proc Natl Acad Sci, 90: 2423–2427, 1993. Maxwell PH. Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER and Ratcliffe PJ: The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399: 271– 275, 1999. McCord JM and Fridovich I: Superoxide dismutase. An enzymic function for erythrocuprein(hemocuprein). J. Biol. Chem. 44: 6049-55, 1969. Meves A, Stock SN, Beyerle A, Pittelkow MR, Peus D: H2O2 mediates oxidative stress-induced epidermal growth factor receptor phosphorylation. Toxicology Letters 122: 205-214, 2001. Millikan D, Meese E, Vogelstein B, Witkowski C and Trent J: Loss of heterozygosity for loci on the long arm of chromosome 6 in human malignant melanoma. Cancer Res. 51: 5449-5453, 1991. Mohamed KM, Le A, Duong H, Wu Y, Zhang Q and Messadi DV: Correlation between VEGF and HIF-1α expression in human oral squamous cell carcinoma. Exp. Mol. Pathology 76: 143-152, 2004. North S, Moenner M and Bikfalvi A: Recent developments in the regulation of the angiogenic switch by cellular stress factors in tumors. Cancer Lett. 218: 1-14, 2005. O’Relly MS, Holmgren L, Folkman JC. Chen: Angiostatin induces and sustains dormancy of human primary tumors in mice, Nat. Med. 2: 689-692, 1996. Oberley LW and Oberley TD: Reactive oxygen species in the aetiology of cancer. In: Ioannides C, Lewis DV, editors. Drugs, Diet, and Disease, Vol. 1. Prentice Hall; p. 49–63. 1994. Oberley LW and Oberley TD: Role of antioxidant enzymes in cell immortalization and transformation. Mol. Cell Biochem. 84: 147-153, 1988. Oberley LW, Oberley TD, Free radicals, cancer, and aging, In Johnson J.E., Walford R., Harmon D., Miquel J., (Ed.) Free Radicals, Aging, and Degenerative Diseases, (1986), Alan R Liss Inc, New York. pp. 325—381 Oberley LW., Superoxide dismutase and cancer, In Oberley LW, (Ed.) Superoxide Dismutase, Vol. II: Boca Rotan, (1982), CRC Press. Chapter 6 Oberley LW: Mechanism of the tumor suppressive effect of MnSOD overexpression. Biomed. Pharmacotherapy. 59: 143-8, 2005. Oberley T.D, Oberley LW, Oxygen radicals and cancer, Yu B.P., (Ed.) Free Radicals in Aging, (1993), CRC Press, Boca Raton. pp. 248—267 O'Kelly I, Lewis A, Peers C and Kemp PJ: O2 Sensing by airway chemoreceptor-derived cells. J. Biol. Chem. 275: 7684-7692, 2000. Pardal R, Ludewig U, Garcia-Hirschfeld J. and Lopez-Barneo J: Secre- tory responses of intact glomus cells in thin slices of rat carotid body to hypoxia and tetraethylammonium. Proc. Natl. Acad. Sci. USA. 97: 2361-6, 2000. Peng XH, Karna P, Cao Z, Jiang BH, Zhou M and Yang L: Cross-talk between epidermal growth factor receptor and hypoxia-inducible factor-1alpha signal pathways increases resistance to apoptosis by up-regulating survivin gene expression. J. Biol. Chem. 281; 25903-25914, 2006. Peng Y, Yuan G, Overholt JL, Kumar GK and Prabhakar NR: Systemic and cellular responses to intermittent hypoxia: evidence for oxidative stress and mitochondrial dysfunction. Adv. Exp. Med. Biol. 536: 559-64, 2003. Petit AM, Rak J, Hung MC, Rockwell P, Goldstein N, Fendly B and Kerbel RS: Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors. Am. J. Pathol. 151: 1523–1530, 1997. Podmore ID, Griffiths HR, Herbert KE, Mistry N, Mistry P, and Lunec J: Vitamin C exhibits pro-oxidant properties. Nature 392: 559, 1998. Porwol T, Ehleben W, Brand V and Acker H: Tissue oxygen sensor function of NADPH oxidase isoforms, an unusual cytochrome aa3 and reactive oxygen species. Respir. Physiol. 128: 331-348, 2001. Prabhakar NR and Kumar GK: Oxidative stress in the systemic and cellular responses to intermittent hypoxia. Biol. Chem. 385: 217-221, 2004. Quinn MT, Ammons MC and Deleo FR: The expanding role of NADPH oxidases in health and disease: no longer just agents of death and destruction. Clin Sci. 111: 1-20, 2006. Quintanilha AT and packer L: Vitamin E, physical exercise and tissue oxidative damage. Ciba. Found. Symp. 101: 56-69, 1983. Richard DE, Berra E and Pouyssegur J: Angiogenesis: how a tumor adapts to hypoxia. Biochem. Bioph. Res. Commun. 266: 718-22, 1999. Salceda S and Caro J: Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J. Biol. Chem. 272: 22642-22647, 1997. Salomon DS, Brandt R, Ciardiello F and Normanno N: Expression of messenger RNA for amphiregulin, heregulin, and cripto-1, three new members of the epidermal growth factor family, in human breast carcinomas. Breast Cancer Res. Treat. 35: 293-297, 1995. Schafer G, Cramer T, Suske G, Kemmner W, Wiedenmann B and Hocker M: Oxidative stress regulates vascular endothelial growth factor-A gene transcription through Sp1- and Sp3-dependent activation of two proximal GC-rich promoter elements. J. Biol. Chem. 278: 8190-8198, 2003. Semenza GL and Wang GL: A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol. Cell Biol. 12: 5447–5454, 1992. Semenza GL, Nejfelt MK and Chi SM: Hypoxia-inducible nuclear factors bind to an enhancer element located 3" to the human erythropoietin gene. Proc. Natl. Acad. Sci. 88: 5680–5684, 1991. Semenza GL, Roth PH and Fang HM: Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J. Biol. Chem. 269: 23757–23763, 1994. Semenza GL: HIF-1 and tumor progression: pathophysiology and therapeutics. Trends. Mol. Med.8: S62-67, 2002. Semenza GL: Targeting HIF-1 for cancer therapy. Nature Review 3: 721-732, 2003. Sies H: Biochemistry of thiol groups: the role of glutathione. Naturwissenschaften. 76: 57-64, 1989a. Sies H: Relationship between free radicals and vitamins: an overview. Int. J. vitam. Nutr. Res. Suppl. 30: 215-23, 1989b. Skogvall S, Korsgren M and Grampp W: Evidence that neuroepithelial endocrine cell control the spontaneous tone in guinea pig tracheal preparation. J. Appl. Physiol. 86: 789-798, 1999. Szatrowski TP and Nathan CF: Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res. 51; 794-798, 1991. Takigchi N, Saito N, Nunomura M, Kouda K, Oda K, Furrutyama N and Nakajima N: Use of 5-FU plus hyperbaric oxygen for treating malignant tumor: evaluation of antitumor effect and measurement of 5-FU in individual organs. Cancer Chemother. Pharmacol. 47: 11-14, 2001. Talks KL, Turley H, Gatter KC, Maxwell PH, Pugh CW, Ratcliffe PJ and Harris AL: The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages. Am. J. Pathol. 157: 411–421, 2000. Thomas D, Espey M, Ridnour L, Hofseth LJ, Mancardi D, Harnu CC and Wink DA: Hypoxic inducible factor in extracellular signal-regulated kinase and P53 are regulated by distinct threshold concentrations of nitric oxide. Proc.Natl,Acad.Sci.72:485-490, 2004. Thomliinson RH and Gray LH: The histological structure of some human lungcancers and the possible implications for radiotherapy. Br. J. Cancer 9: 539-549, 1995. Thurfjell N, Coates PJ, Boldrup L, Lindgren B, Backlund B, Uusitalo T, Mahani D, Dabelsteen E, Dahlqvist A, Sjostrom B, Roos G, Vojtesek B, Nenutil R and Nylander K: Function and importance of p63 in normal oral mucosa and squamous cell carcinoma of the head and neck. Adv. Otorhinolaryngol 62: 49-57, 2005. Turpaev KT: Reactive oxygen species and regulation of gene expression. Biochemistry (Mosc) 67: 281–292, 2002. Uchida T, Rossignol F, Matthay MA, Mounier R, Couette S, Clottes E and Clerici C: J. Biol. Chem. 279: 14871–14878, 2004. Veikkola T, Karkkainen M, Lena CW and Alitalo K: Regulation of angiogenesis via vascular endothelial growth factor receptors. Cancer Res. 60: 203-212, 2000. Vera E and Quaggin SE: The role of VEGF-A in glomerular development and function. Curr. Opinion Nephrol. hyperten. 13: 9-15, 2004. Vivekananda J, Lin A, Coalson JJ and King RJ: Acute inflammatory injury in the lung precipitated by oxidant stress induces fibroblasts to synthesize and release transforming growth factor-alpha. J. Biol. Chem. 269: 25057-25061, 1994. Wang M, Kirk JS, Venkataraman S, Domann FE, Zhang HJ, Schafer FQ, Flanagan SW, Weydert CJ, Spitz DR, Buettner GR, Oberley LW: Manganese superoxide dismutase suppresses hypoxic induction of hypoxia-inducible factor-1alpha and vascular endothelial growth factor. Oncogene 24; 8154-8166, 2005. Wenger RH: Mammalian oxygen sensing, signaling and gene regulation. J Exp Biol. 203: 1253-1263, 2000. Weissmann N, Tadic A, HÄnze J, Rose F, Winterhalder S, Nollen M, Schermuly RT, Ghofrani HA, Seeger W and Grimminger F: Hypoxic vasoconstriction in intact lungs:a role for NADPH oxisade-derived H2O2 ?.Am J Physiol Lung Cell Mol Physiol. 279: 683-690, 2000. Xu Y, Krishnan A, Wan SX, Majima H, Yeh C-C and Ludewig G: Mutations in the promoter reveal a cause for the reduced expression of the human manganese superoxide dismutase gene in cancer cells, Oncogene 18: 93-102, 1999. Yan T,Oberley LW, Zhong W and St Clair DK: Manganese containing superoxide dismutase overexpression causes phenotypic reversion in SV40-transformed human lung fibroblasts. Cancer Res. 56: 2864-2871, 1996. Yarden Y: The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities. Eur. J. Cancer 37: S3-8, 2001. Yasuda M, Ohzeki Y, Shimizu S, Naito S, Ohtsuru A, Yamamoto T, and Kuroiwa Y: Stimulation of in vitro angiogenesis by hydrogen peroxide and the relation with ETS-1 in endothelial cells, Life Sci. 64: 249-258, 1999. Yeldandi AV, Rao MS and Reddy JK: Hydrogen peroxide generation in peroxisome proliferator-induced oncogenesis. Mutat. Res. 448: 159–177, 2000. Yu BP: Cellular defenses against damage from reactive oxygen species. Physiol. Rev. 74: 139-162, 1994. Zang Q,Thomas SM, Xi S, Smithgall TE, Siegfried JM, Kamens J, Gooding WE and Grandis JR: SRC family Kinases mediate epidermal groeth factor receptor ligand cleavage,proliferation and invasion of head and neck cancer cell. Cancer Research. 64:6166-6173, 2004. Zhong W, Oberley LW, Oberley TD and St Clair DK: Suppression of the malignant phenotype of human glioma cells by overexpression of manganese superoxide dismutase. Oncongene 14:481-490, 1997. Zhong H, Chiles K, Feldser D, Laughner E, Hanrahan C, Georgescu MM, Simons JW and Semenza GL: Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN /A -KT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res. 60: 1541–1545, 2000. Zhong,H, De Marzo AM, Laughner E, Lim M, Hilton DA, Zagzag D, Buechler P, Isaacs WB, Semenza GL and Simons JW: Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases. Cancer Res. 59, 5830–5835, 1999. Zhou J, Schmid T, Schnitzer S and Brune B: Tumor hypoxia and cancer progession.Cancer Letters 1-12, 2005. Zong W, Oberley LW, Oberley TD and Clair DK: Suppression of the malignant phenotype of human glioma cell by overexpression of manganese superoxide dismutase. Oncogen 14: 481-490, 1997. Zundel W, Schinder C, Haas-Kogan D, Koong A, Kaper F, Chen E, Gottschalk AR, Ryan HE,Johnson RS, Jefferson AB, Stoke D, Giaccia AJ: Loss of PTEN facilitates HIF-1-mediated gene expression. Genes Dev 14:391-6, 2000. 林曜祥、任益民、林釗正、李日清、王炳龍:台灣地區頭頸癌概況。中耳醫誌。37:176-182,2002.
|